Has Richard Callado received payments from drug or device companies?

Yes. Drug and device makers reported $47,209 in general payments to Richard Callado across 223 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Richard Callado did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Richard Callado come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Richard Callado

Psychiatric/Mental Health · New York, NYNPI 1952962227

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by AbbVie at 40.4% of the total. 2025 is the largest year on record at $28,987, more than ten times the $425 reported in 2021. Among psychiatric/mental health clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$47,209in general payments, 2019–2025

Across 223 payments — averaging $211.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$19K
E.r. Squibb & Sons, L.L.C.$13K
Alkermes, Inc.$10K
Otsuka Pharmaceutical Development & Commercialization, Inc.$3K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$648
Vanda Pharmaceuticals Inc.$401
plus $476 from 4 others

What the payments were for

Consulting fees$15,21032%
Speaking & faculty fees$20,39243%
Travel & lodging$3,4357%
Food & beverage$8,15117%
Education$210%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	106	$19,049
E.r. Squibb & Sons, L.L.C.	29	$13,321
Alkermes, Inc.	33	$9,989
Otsuka Pharmaceutical Development & Commercialization, Inc.	10	$3,325
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	16	$648
Vanda Pharmaceuticals Inc.	13	$401
Otsuka America Pharmaceutical, Inc.	5	$234
Teva Pharmaceuticals USA, Inc.	4	$109
Supernus Pharmaceuticals, Inc.	6	$109
Indivior Inc.	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,209 in reported general payments places this provider in the 95th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Other psychiatric/mental health in New York

Darcy LeonNew York$37K
Angela AnukamNew York$11K
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K
Daniel BreeyearNiskayuna$149K
Elijah StevensBinghamton$131K
Kayanna JonasFar Rockaway$93K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →